Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease

H L Sweeney1, H S Feng, Z Yang

  • 1Department of Physiology, A700 Richards Building, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6085, USA. lsweeney@mail.med.upenn.edu

Insights

Cardiac troponin T (TnT) mutations can cause hypertrophic cardiomyopathy (HCM) through altered muscle contraction. These TnT mutations impair calcium sensitivity and increase shortening velocity, suggesting a new mechanism for HCM development.

Area of Science:

  • Cardiovascular Biology
  • Muscle Physiology
  • Genetic Diseases

Background:

  • Hypertrophic cardiomyopathy (HCM) is often caused by mutations in sarcomeric protein genes.
  • Previous research suggested some HCM mutations impair cardiac muscle contractile function.
  • A specific troponin T (TnT) mutation was hypothesized to cause hypercontractility, indicating a different pathogenic mechanism.

Purpose of the Study:

  • To investigate the functional effects of three HCM-associated cardiac troponin T (TnT) mutations.
  • To determine if these TnT mutations alter myotube contractile properties.
  • To explore a potential second mechanism for HCM pathogenesis involving TnT.

Main Methods:

  • Utilized a myotube expression system to study wild-type and mutant cardiac troponin T (TnT).
  • Performed functional analyses on transfected myotubes to assess force production and shortening velocity.
  • Investigated the impact of specific TnT mutations (Ile79Asn, Arg92Gln, DeltaGlu160) on calcium sensitivity.

Main Results:

  • All three studied cardiac troponin T (TnT) mutations reduced calcium sensitivity in force production.
  • Two missense TnT mutations (Ile79Asn and Arg92Gln) significantly increased unloaded shortening velocity.
  • The findings indicate TnT's role in modulating myosin cross-bridge detachment rates.

Conclusions:

  • The troponin complex plays a more significant role in regulating muscle contraction than previously understood.
  • These TnT mutations may lead to HCM by increasing the heart's energetic workload.
  • This suggests a distinct pathogenic pathway for hypertrophic cardiomyopathy (HCM) driven by TnT mutations.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each myosin...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...